Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Award

The esteemed ESMO Award was established in 1985 to recognise an ESMO member who has made an outstanding contribution to the development of medical oncology by promoting it as a specialty within the European and/or international community.

2024 - Ann Partridge, USA

partridge-ann

The 2024 ESMO Award will be presented to Ann Partridge at the ESMO 2024 Opening Ceremony. Partridge is Vice chair of the Department of Medical Oncology at Dana-Farber Cancer Institute, USA, where she also serves as Director of the Adult Survivorship Program and leads the Program for Young Women with Breast Cancer. A Professor of medicine at Harvard Medical School, she holds the Eric P. Winer, MD Chair in Breast Cancer Research at Dana-Farber.

Her clinical research focuses on improving the care and outcomes of patients with cancer, with an emphasis on treatment, survivorship, and psychosocial issues facing women with breast cancer.

Partridge is being recognised for her work and commitment to advancing the field of breast cancer, which has led to significant advancements in understanding breast cancer and caring for those who develop the disease.

Previous recipients of the ESMO Award:

  • Isabelle Ray-Coquard, France (2023)
  • Karim Fizazi, France (2022)
  • Lisa Licitra, Italy (2021)
  • Hans-Joachim Schmoll, Germany (2020)
  • Eric Van Cutsem, Belgium (2019)
  • Jean-Charles Soria, USA (2018)
  • Miguel Martin, Spain (2017)
  • Alberto Sobrero, Italy (2016)
  • Nathan Cherny, Israel (2015)
  • Carsten Bokemeyer, Germany (2014)
  • Cora Sternberg, Italy (2013)
  • Ian Tannock, Canada (2012)
  • Johann de Bono, United Kingdom (2011)
  • Alberto Costa, Italy (2010)
  • E.G. Elisabeth de Vries, The Netherlands (2009)
  • Jean-Pierre Armand, France (2008)
  • Jan B. Vermorken, Belgium (2007)
  • David J. Kerr, United Kingdom (2006)
  • José Baselga, Spain (2005)
  • Allan T. van Oosterom, Belgium (2004)
  • Maurice Schneider, France (2002)
  • Robert Souhami, United Kingdom (2000)
  • D. J. Theo Wagener, The Netherlands (1998)
  • Martine Piccart, Belgium (1997)
  • Stanley B. Kaye, United Kingdom (1995)
  • Pierre Alberto, Switzerland (1993)
  • Franco Cavalli, Switzerland (1991)
  • Gianni Bonadonna, Italy (1989)
  • Heine H. Hansen, Denmark (1987)
  • Herbert Michael Pinedo, The Netherlands (1985)

Nomination and selection process

Nominations may be made by any ESMO member (except undergraduate medical or science student members). Candidates may not nominate themselves.

Candidate eligibility criteria

  • Be an individual (institutions and organisations are not eligible) who has contributed continuously by outstanding scientific contributions to the development of understanding malignancies and/or their treatment
  • Be an ESMO member
  • Be an oncology professional, medical or clinical oncologist
  • Have not previously received the ESMO Award
  • Have not received any other Award from ESMO within the last five (5) years
  • Not be a current or recent (last two years) member of either the ESMO Executive BoardESMO Council or the ESMO Nomination Committee

Final selection is made by the Selection Committee: ESMO President, ESMO President-Elect, ESMO Past-President, Chair of the ESMO Nomination Committee.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.